Media

June 28, 2021 – Journal Métro

Nouvel espoir d’un traitement canadien peu coûteux contre la COVID-19

June 28, 2021 – Journal Métro

Nouvel espoir d’un traitement canadien peu coûteux contre la COVID-19

June 17, 2021 – MUHC Foundation

Dr. Jean Bourbeau on a promising new treatment to prevent severe COVID-19

June 14, 2021 – Fondation du CUSM

L’essai clinique nord-américain de phase III d’un traitement COVID débute suite à l’approbation de la FDA et de Santé Canada

June 14, 2021 – Canadian Manufacturing

McGill University Health Centre begins phase III trial for its COVID-19 anti-inflammatory drug

June 14, 2021 – National Post

Phase III North American Clinical Trial for COVID-19 Treatment begins after FDA & Health Canada approval

June 14, 2021 – Global News

Affordable, decades-old drug PULM-001 proves promising in the fight against COVID-19

May 1st, 2021 – Radio-Canada

Portrait de médecin  :  Dr Houfar Sekhavat

January 27 , 2021 – The Hill Time

Research team struggles to find public funds for low-cost generic drug that could treat COVID-19

October 9, 2020 – Radio-Canada

16:39 | Une start-up de Dieppe développe un traitement contre la COVID

September 30, 2020 – The Star

Narrow focus on vaccines is a risk we can’t afford

September 22, 2020 – The McGill Tribune

Canadian Biotech start-up to begin Phase 3 COVID-19 oral treatment trials

September 11, 2020 – Radio-Canada

La course au financement de remèdes contre la COVID-19 tiraille des scientifiques

September 7, 2020 – Global News

Developing coronavirus treatments ‘extremely important,’ experts say

September 3, 2020 – Radio-Canada

Un médicament contre la COVID-19 en cours d’élaboration à Dieppe

September 3, 2020 – TVA Nouvelles

Un autre médicament contre la COVID-19 testé au Québec

September 3, 2020 – La Presse

Un médicament générique contre la COVID-19 testé à Montréal

September 3, 2020 – Radio-Canada

Interview with Dr Jean Bourbeau (in French)

September 3, 2020 – Journal de Montréal

Un autre médicament contre la COVID-19 testé au Québec

September 3, 2020 – Complex

Canadian Drug Approved for Trials as COVID-19 Treatment Could Be Available This Year

September 3, 2020 – Narcity

A Canadian COVID-19 Treatment Just Got Phase 3 Trial Approval From The Government (VIDEO)

September 3, 2020 – Medical News

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

September 2, 2020 – 98.5 Montreal

Dr Jean Bourbeau radio interview on 98.5 Montreal with Paul Arcand (in French)

September 2, 2020 – News release

Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19

September 2, 2020 – News release

New COVID-19 Drug Therapy Developed by Canadian Biotech Start-up Headed for Phase III Clinical Trial Sponsored by the RI-MUHC

Looking to Invest?

Interested in investing or participating in the Clinical Trial?

Please complete the form below or email us at info@pulmonem.ca

    Interests
    Clinical trialPotential investorBusiness (supplier, distributor, etc)Other

    Pulmonem Inc.
    855, Dieppe Blvd
    Dieppe, NB  E1A 7R8
    CANADA

    Media Enquiries
    Keelan Green
    613-220-2016
    green@prospectus.ca